These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 19059572)
21. Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome. Mahmoudi M; Delhaye C; Waksman R Cardiovasc Revasc Med; 2011; 12(6):385-90. PubMed ID: 21330220 [TBL] [Abstract][Full Text] [Related]
22. Balancing hemorrhagic and thrombotic complications in a patient with a very late paclitaxel-eluting stent thrombosis: a clinical case report. Esposito G; Cassese S; Gargiulo G; Sannino A; Schiattarella GG; Piscione F; Chiariello M J Cardiovasc Med (Hagerstown); 2011 May; 12(5):366-9. PubMed ID: 20407382 [TBL] [Abstract][Full Text] [Related]
23. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Park DW; Park SW; Park KH; Lee BK; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ Am J Cardiol; 2006 Aug; 98(3):352-6. PubMed ID: 16860022 [TBL] [Abstract][Full Text] [Related]
24. Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents. Lemesle G; Torguson R; Bonello L; de Labriolle A; Maluenda G; Ben-Dor I; Collins SD; Syed AI; Xue Z; Satler LF; Pichard AD; Waksman R EuroIntervention; 2011 Apr; 6(9):1053-9. PubMed ID: 21518676 [TBL] [Abstract][Full Text] [Related]
26. [Late stent thrombosis after drug-eluting stent implantation: epidemiological, clinical and pathophysiological aspects]. Notaristefano S; Sbarzaglia P; Cavallini C G Ital Cardiol (Rome); 2008 Oct; 9(10):674-83. PubMed ID: 18942555 [TBL] [Abstract][Full Text] [Related]
27. Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus. Maeng M; Jensen LO; Kaltoft A; Hansen HH; Bøttcher M; Lassen JF; Thayssen P; Krusell LR; Rasmussen K; Pedersen L; Sørensen HT; Johnsen SP; Thuesen L Am J Cardiol; 2008 Jul; 102(2):165-72. PubMed ID: 18602515 [TBL] [Abstract][Full Text] [Related]
28. Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and design. Tamburino C; Capodanno D; La Manna A; di Salvo M; Sanfilippo A; Prati F J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):53-8. PubMed ID: 19829136 [TBL] [Abstract][Full Text] [Related]
29. Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727 [TBL] [Abstract][Full Text] [Related]
30. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries. Lasala JM; Cox DA; Dobies D; Baran K; Bachinsky WB; Rogers EW; Breall JA; Lewis DH; Song A; Starzyk RM; Mascioli SR; Dawkins KD; Baim DS; Circ Cardiovasc Interv; 2009 Aug; 2(4):285-93. PubMed ID: 20031730 [TBL] [Abstract][Full Text] [Related]
31. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Applegate RJ; Sacrinty MT; Kutcher MA; Santos RM; Gandhi SK; Little WC Circ Cardiovasc Interv; 2009 Feb; 2(1):35-42. PubMed ID: 20031691 [TBL] [Abstract][Full Text] [Related]
32. High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis. Lemesle G; Sudre A; Modine T; Delhaye C; Rosey G; Gourlay T; Bauters C; Lablanche JM Catheter Cardiovasc Interv; 2008 Oct; 72(4):470-8. PubMed ID: 18814219 [TBL] [Abstract][Full Text] [Related]
33. Drug-eluting versus bare metal stenting in acute myocardial infarction. A clinical review. Jones WS; Washam JB; Meine TJ; Patel MR Minerva Cardioangiol; 2009 Oct; 57(5):585-95. PubMed ID: 19838149 [TBL] [Abstract][Full Text] [Related]
34. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials. Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858 [TBL] [Abstract][Full Text] [Related]
35. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives. Ducrocq G; Serebruany V; Tanguay JF Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923 [TBL] [Abstract][Full Text] [Related]
37. Drug-eluting stents and stent thrombosis: a cause for concern? Wernick MH; Jeremias A; Carrozza JP Coron Artery Dis; 2006 Dec; 17(8):661-5. PubMed ID: 17119373 [TBL] [Abstract][Full Text] [Related]
38. Long stents as a risk factor for late stent thrombosis size does matter. Tommaso CL JACC Cardiovasc Interv; 2010 Apr; 3(4):390-1. PubMed ID: 20398865 [No Abstract] [Full Text] [Related]
39. Bare metal stent thrombosis 13 years after implantation. Sarkees ML; Bavry AA; Galla JM; Bhatt DL Cardiovasc Revasc Med; 2009; 10(1):58-9. PubMed ID: 19159857 [TBL] [Abstract][Full Text] [Related]
40. Stent thrombosis: role of compliance and nonresponsiveness to antiplatelet therapy. Gurbel PA; Tantry US Rev Cardiovasc Med; 2007; 8 Suppl 1():S19-26. PubMed ID: 17401307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]